2012:
- Organizing the Heterogeneity in High-Grade Serous Ovarian Cancer by Mass Cytometry
- Genetic Profiling in the Australian Ovarian Cancer Study
- Premalignant Expression Signature in BRCA-1-mediated Ovarian Cancer
- Understanding Ovarian Cancer Risk Factors
- New Agents for Taxol-Resistant Ovarian Carcinoma
2011:
- Ovarian Autoantibodies Predict Ovarian Cancer
- Structural and Functional Analysis of CA125: Potential for Early Diagnosis and Understanding the Immune Evasion Strategies of Epithelial Ovarian Tumors
- Mumps Parotitis and Ovarian Cancer: Modern Significance of an Historic Association
- Targeting Ovarian Cancer
2010:
- Use of Novel Technologies to Identify and Investigate Molecular Markers for Ovarian Cancer Screening and Prevention - Paving the Way for the Pacific Ovarian Cancer Research Consortium
- Molecular Epidemiology of Ovarian Cancer - Australian Ovarian Cancer Study
- The Biological Basis for Chemoprevention of Ovarian Cancer - The International Ovarian Cancer Association Consortium
2009:
- Affinity-Based Serum Proteomics for Ovarian Cancer Early Diagnosis
- Resveratrol and Autophagy: Inhibiting Glucose Metabolism to Overcome Chemoresistance
- Polymorphisms, Risk, and the Chemoprevention of Ovarian Cancer
2008:
- Eliciting Autoimmunity to Ovarian Tumors in Mice by Genetic Disruption of T Cell Tolerance Mechanisms
- Role of Prohibitin in Ovarian Cancer Growth and Apoptotic Mechanisms
- Improving Quality of Life for Women Confronting Ovarian Cancer
- Development and Characterization of Animal Models
2007:
- Novel Computational Biology Technologies to Identify Ovarian Cancer Biomarkers that Predict Survival
- New Animal Model to Study Ovarian Cancer
- Ovarian Granulosa Cells Show a New Mechanism for BRCA1-Induced Ovarian Tumorigenesis
- Ovarian Cancer Detection by Elevated Urinary Levels of Bcl2
2006:
- A Novel Technology for Early Detection of Serum LPAs in Ovarian Cancer
- Tipping the Balance: KLF6 Isoforms and Ovarian Cancer
- Novel bioinformatics approach to epithelial ovarian cancer marker identification
- New Molecular Technology to Identify Candidate Ovarian Cancer Oncogenes
- Liposome-Based Radiotherapies for the Treatment of Ovarian Cancer
- Training our Nation's Finest Researchers
2005:
- HOXA9, HOXA10, and HOXA11 as molecular markers and therapeutic targets in ovarian cancer
- Mutant Endostatin: Promising Antiangiogenic Therapeutic Agent for Ovarian Cancer
- Anti-Angiogenic Role of Dendritic Cells in Ovarian Cancer
- Novel Serum Biomarkers for the Detection of Ovarian Cancer
- Squalamine and Cisplatin: Potential Ovarian Cancer Therapeutic Agents
2004:
- Development of a Novel Vaccine with Fusions of Dendritic and Ovarian Cancer Cells from Patients
- Blockade Of B7-H1 Improves Myeloid Dendritic Cells Mediated Antitumor Immunity In Ovarian Cancer
- The Use of the Sindbis Vector to Combat Ovarian Cancer
- The Effects of a Vitamin C Derivative on Ovarian Cancer
2003:
2002:
- New Anti-Metastatic and Anti-Angiogenic Compound for Ovarian Cancer
- Development of a Novel Vaccine with Fusions of Dendritic and Ovarian Cancer Cells from Patients
- Regulation of Telomerase Activity in Ovarian Cancer
- Facilitating Decision-Making about Prophylactic Oophorectomy
